Fresenius SE KGaAXSWX:FRE 70 Equity-to-Asset is 0.47 as of Mar. 2026, which is 74% above its 10-year median of 0.27. GuruFocus rates XSWX:FRE with a GF Score™ of 70/100 and a GF Value™ of CHF32.58 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 685 Healthcare Providers & Services companies, Fresenius SE KGaA ranks worse than 51.82% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Fresenius SE KGaA's Total Stockholders Equity for the quarter that ended in Mar. 2026 was CHF18,006 Mil. Fresenius SE KGaA's Total Assets for the quarter that ended in Mar. 2026 was CHF38,564 Mil.
Therefore, Fresenius SE KGaA's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.47.
The historical rank and industry rank for Fresenius SE KGaA's Equity-to-Asset or its related term are showing as below:
XSWX:FRE'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.25 Med: 0.27 Max: 0.47
Current: 0.47
During the past 13 years, the highest Equity to Asset Ratio of Fresenius SE KGaA was 0.47. The lowest was 0.25. And the median was 0.27.
XSWX:FRE's Equity-to-Asset is ranked worse than 51.82% of 685
companies
in the Healthcare Providers & Services industry
Industry Median: 0.5
vs XSWX:FRE: 0.47
Fresenius SE KGaA (XSWX:FRE) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Fresenius SE KGaA Equity-to-Asset Related Terms
Fresenius SE KGaA Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Fresenius SE KGaA's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:FRE vs HCA, THC, DVA: Equity-to-Asset Comparison
For the Medical Care Facilities subindustry, Fresenius SE KGaA's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius SE KGaA Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Fresenius SE KGaA's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Fresenius SE KGaA's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius SE KGaA (XSWX:FRE) has a Equity-to-Asset of 0.47 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Fresenius SE KGaA and its competitors. This is 74% above median its historical median of 0.27. Over the past decade, Fresenius SE KGaA's Equity-to-Asset has ranged from 0.25 to 0.47. According to the industry distribution chart, Fresenius SE KGaA ranks #355 out of 685 companies in the Healthcare Providers & Services industry, placing it in the top 51.8%.
Is Fresenius SE KGaA's Equity-to-Asset too high?
Fresenius SE KGaA's current Equity-to-Asset of 0.47 is 74% above median its 10-year median of 0.27. Over the past 10 years, this metric has ranged from a low of 0.25 to a high of 0.47. The Healthcare Providers & Services industry median Equity-to-Asset is 0.50. Fresenius SE KGaA's value of 0.47 is 6% below this industry median. Based on the distribution chart, Fresenius SE KGaA ranks #355 out of 685 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Fresenius SE KGaA has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's Equity-to-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #355 out of 685 companies for Equity-to-Asset. This places Fresenius SE KGaA in the lower half of its industry. The industry median Equity-to-Asset is 0.50. Fresenius SE KGaA's value of 0.47 is 6% below this benchmark. Historically, Fresenius SE KGaA's own Equity-to-Asset has ranged from 0.25 to 0.47 over the past decade. While the company's 10-year median is 0.27 vs. the industry median of 0.50, Fresenius SE KGaA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.50, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius SE KGaA's current Equity-to-Asset of 0.47 is 6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Fresenius SE KGaA and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius SE KGaA's current Equity-to-Asset is 0.47, which is 74% above median its own 10-year median of 0.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF32.58, compared to a current price of CHF37.79 — trading 16% above its estimated fair value. The current Equity-to-Asset is 0.47, which is 74% above median its 10-year median of 0.27 and 6% below the Healthcare Providers & Services industry median of 0.50. Fresenius SE KGaA's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current Equity-to-Asset is 0.47 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued.
The current stock price of CHF37.79 is trading 16% above its estimated GF Value™ of CHF32.58.
GuruFocus considers Fresenius SE KGaA to be Modestly Overvalued.
Key valuation signals for XSWX:FRE:
Equity-to-Asset: 0.47 (74% above median its 10-year median of 0.27)
GF Value™: CHF32.58 vs. price of CHF37.79 (16% above fair value)
Industry Position: 6% below the Healthcare Providers & Services median (#355 of 685)
No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
70GF Score
Get the complete analysis for XSWX:FRE
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FRE has been successfully added to your 
